Lobeline

Lobeline

SCHEMBL4264391

Br.CN1[C@@H](CC(=O)c2ccccc2)CCC[C@H]1C[C@H](O)c1ccccc1

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Lobeline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.97
CYP1A2 P05177 3/20 0.97
TSHR P16473 1/20 0.97
NFKB1 P19838 1/20 0.97
LMNA P02545 1/20 0.97
CHRNB2 P17787 1/20 0.97
HTR2A P28223 1/20 0.97
HRH1 P35367 1/20 0.97
CHRNA7 P36544 1/20 0.97
CHRNA4 P43681 1/20 0.97
SLC18A2 Q05940 1/20 0.97
HIF1A Q16665 1/20 0.72
KCNH2 Q12809 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lobeline SCHEMBL14029403 0.99 CYP2D6 (1.00) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL3308906 0.99 CYP2D6 (1.00) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL290804 0.99 CYP2D6 (1.00) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL13900378 0.99 CYP2D6 (1.00) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL290803 0.99 CYP2D6 (1.00) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL2905547 0.99 CYP2D6 (1.00) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL8305826 0.99 CYP2D6 (1.00) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL467021 0.97 CYP2D6 (0.97) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL8994428 0.97 CYP2D6 (0.97) CYP2D6CYP1A2TSHRNFKB1LMNA
Lobeline SCHEMBL467022 0.97 CYP2D6 (0.97) CYP2D6CYP1A2TSHRNFKB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3391884-B1 TRANSDERMALLY ABSORBABLE PREPARATION KM TRANSDERM LTD (JP) 2024-04-10 EP disclosed
US-11786480-B2 Transdermally absorbable preparation KM Transderm Ltd. (JP) 2023-10-17 US disclosed
EP-3040068-B1 ADHESIVE SHEET FOR APPLICATION TO THE SKIN, AND PERCUTANEOUS ABSORPTION PREPARATION USING SAME KM TRANSDERM LTD (JP) 2021-08-18 EP disclosed
EP-3254677-B1 ADHESIVE PATCH HISAMITSU PHARMACEUTICAL CO (JP) 2021-08-04 EP disclosed
US-20210062053-A1 ADHESIVE SHEET FOR SKIN PATCH KANEKA CORPORATION (JP) 2021-03-04 US disclosed
EP-3744349-A1 ADHESIVE SHEET FOR ATTACHMENT TO SKIN Kaneka Corporation (JP) 2020-12-02 EP disclosed
CN-107205957-B Patch preparation 久光制药株式会社 2020-12-01 CN disclosed
US-20200214991-A1 ADHESIVE SHEET FOR APPLICATION TO THE SKIN, AND PERCUTANEOUS ABSORPTION PREPARATION USING SAME KM Transderm Ltd. (JP) 2020-07-09 US disclosed
US-10314791-B2 Adhesive sheet for attachment to skin and percutaneous absorption preparation using same KM Transderm Ltd. (JP) 2019-06-11 US disclosed
US-10292941-B2 Adhesive patch HITSAMITSU PHARMACEUTICAL CO., INC. (JP) 2019-05-21 US disclosed
US-20130226112-A1 PERCUTANEOUS ABSORBENT AND ADHESIVE SHEET FOR SKIN PATCH MEDRX CO., LTD. (JP) 2013-08-29 US disclosed
EP-2614819-A1 PERCUTANEOUS ABSORBENT AND ADHESIVE SHEET FOR SKIN PATCH KM Transderm (JP) 2013-07-17 EP disclosed
EP-1806152-B1 Drug for external use and adhesive patch HISAMITSU PHARMACEUTICAL CO (JP) 2012-08-01 EP disclosed
EP-1806151-B1 DRUG FOR EXTERNAL USE AND ADHESIVE PATCH HISAMITSU PHARMACEUTICAL CO (JP) 2012-05-23 EP disclosed
US-20090238860-A1 Adhesive Patch Less Irritative to Skin HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2009-09-24 US disclosed
EP-1925299-A1 ADHESIVE PATCH LESS IRRITATIVE TO SKIN HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2008-05-28 EP disclosed
US-20080089925-A1 Drug for External Use and Adhesive Patch HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2008-04-17 US disclosed
US-20070298089-A1 Drug for External Use and Adhesive Patch HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2007-12-27 US disclosed
EP-1806151-A1 DRUG FOR EXTERNAL USE AND ADHESIVE PATCH Hisamitsu Pharmaceutical Co., Ltd. (JP) 2007-07-11 EP disclosed
EP-1806152-A1 DRUG FOR EXTERNAL USE AND ADHESIVE PATCH HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2007-07-11 EP disclosed